SGI-110

guadecitabine · Astex Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for SGI-110, covering 2015-11-18 to 2025-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer. [Phase 1]

See pricing